Skip to content
value.today

Molecular Assemblies, Inc.

🇺🇸 San Diego, California, USABiotechnologyFounded 2013
Total raised
$47 M
3 rounds on record
Latest round
$26 M
Sep 2021
First round on record
Sep 2016
Today
Acquired
Acquired by Maravai LifeSciences Holdings, Inc.

Acquired

Matched to this startup by its exact name; the buyer's report is the source.

Acquisition of Molecular Assemblies, Inc.
AcquiredBuyerAcquisition dateCompletionPriceStakeSource
Molecular Assemblies, IncMaravai LifeSciences Holdings, Inc.2025—$11 M—Annual report

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Molecular Assemblies, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2021$26 MNo. 3$10 to $50 million

Molecular Assemblies, Inc.: Raise no. 3, Sep 2021

Investors in this round

14 investors had bought by the notice of Sep 26, 2022: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$26 M of $40 M offered; $14 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • J. William Efcavitch, Ph.D. · Executive Officer, Director · Treasurer and Chief Scientific Officer
  • Michael J. Kamdar · Executive Officer, Director · President, Chief Executive Officer and Secretary
  • Helge William Bastian · Director
  • Jeffrey William Sampson, Ph.D. · Director
  • John William Nicols · Director
  • Larry William Stambaugh · Director · Chairman of the Board of Directors
  • Todd William Peterson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael J. Kamdar, President and Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Sep 26, 2022. Read the notice at the SEC.

equitySEC
Sep 2019$14 MNo. 2$10 to $50 million

Molecular Assemblies, Inc.: Raise no. 2, Sep 2019

Investors in this round

22 investors had bought by the notice of Sep 24, 2021: 22 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $16 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • J. William Efcavitch, Ph.D. · Executive Officer, Director · Treasurer and Chief Scientific Officer
  • Michael J. Kamdar · Executive Officer, Director · President, Chief Executive Officer and Secretary
  • David William Hwang · Director
  • Helge William Bastian · Director
  • John William Nicols · Director
  • Larry William Stambaugh · Director · Chairman of the Board of Directors
  • Todd William Peterson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael J. Kamdar, President and Chief Executive Officer. Source: SEC Form D and 2 amendments, newest notice filed Sep 24, 2021. Read the notice at the SEC.

equitySEC
Sep 2016$6 MNo. 1$2 to $10 million

Molecular Assemblies, Inc.: Raise no. 1, Sep 2016

Investors in this round

36 investors had bought by the notice of Jul 11, 2018: 36 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $10 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • J. William Efcavitch, Ph.D. · Director, Executive Officer · Treasurer and Chief Scientific Officer
  • Michael J. Kamdar · Director, Executive Officer · President and Chief Executive Officer
  • Sean William Freeman · Executive Officer, Director · Secretary
  • Joe H. Smith · Director
  • Larry H. Stambaugh · Director · Chairman of the Board of Directors

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael J. Kamdar, President and Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jul 11, 2018. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Molecular Assemblies, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2022).

    SEC Form D · Sep 2022

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Sep 2022

That is all the official record says: Molecular Assemblies, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Molecular Assemblies, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 36 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Molecular Assemblies, Inc.
NameRoleNamed in
J. William Efcavitch, Ph.D.Treasurer and Chief Scientific OfficerSep 2022
Michael J. KamdarPresident, Chief Executive Officer and SecretarySep 2022
Sean William FreemanSecretaryOct 2019
Curt William BeckerSecretary, CFO and Chief Commercial OfficerAug 2017
Helge William BastianDirectorSep 2022
J. William Efcavitch, Ph.D.Treasurer and Chief Scientific OfficerSep 2022
Jeffrey William Sampson, Ph.D.DirectorSep 2022
John William NicolsDirectorSep 2022
Larry William StambaughChairman of the Board of DirectorsSep 2022
Michael J. KamdarPresident, Chief Executive Officer and SecretarySep 2022
Todd William PetersonDirectorSep 2022
David William HwangDirectorSep 2021
David H. HwangDirectorOct 2019
Helge H. BastianDirectorOct 2019
Joe H. SmithDirectorOct 2019
Larry H. StambaughChairman of the Board of DirectorsOct 2019
Sean William FreemanSecretaryOct 2019
Curt William BeckerSecretary, CFO and Chief Commercial OfficerAug 2017

Acquired (Jan 1, 2025). Acquired by Maravai LifeSciences Holdings, Inc..